Valproate-Induced Encephalopathy

J Gordon Millichap

doi:10.15844/pedneurbriefs-14-1-6

Valproate-Induced Encephalopathy

Pediatric Neurology Briefs

Volume 14 (2000): Issue 1

By: J Gordon Millichap

Open Access

|Jan 2000

Abstract

Two adults, aged 32 and 37, with focal epilepsy developed hyperammonemic encephalopathy when treated with a combination of valproate (VPA) and topiramate (TPM) at the University of Marburg, Germany.

References

Hamer HM Knake S Schomburg U Rosenow F Valproate-induced hyperammonemic encephalopathy in the presence of topiramate Neurology 2000 Jan 11 54 1 230 232 10.1212/WNL.54.1.230 10636156
Open DOI Search in Google Scholar Back to article
Forget PPh van Oosterhout M Bakker JA Wermuth B Vles JS Spaapen LJ Partial N-acetyl-glutamate synthetase deficiency masquerading as a valproic acid-induced Reye-like syndrome Acta Paediatr 1999 Dec 88 12 1409 1411 10.1111/j.1651-2227.1999.tb01062.x 10626533
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-14-1-6 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 6 - 7

Published on: Jan 1, 2000

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Valproate,

Topiramate,

Hyperammonemic Encephalopathy

© 2000 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 14 (2000): Issue 1